Articles from TVM Capital Healthcare

The commitment, up to USD8 million, underscores investor confidence in healthcare growth opportunities across Southeast Asia, the sector's resilience amid global uncertainty, and TVM Capital Healthcare's proven track record achieving superior financial returns and impact outcomes

TVM Capital Healthcare, an international healthcare expansion and growth capital firm, today announced a USD 35 million investment in Boston Oncology Arabia, a bio-generic drugs manufacturing company based in the Kingdom of Saudi Arabia. From its headquarters in Riyadh and production facility in Sudair Industrial City, Boston Oncology Arabia provides vital medicines for critical conditions through the local development and manufacturing of internationally licensed, best-in-class therapeutics.

TVM Capital Healthcare, an international healthcare expansion and growth capital investor, today announced the closing of the TVM Healthcare Afiyah Fund LP at approximately USD 250 million, its second pool of capital in the Middle East.